Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids

International Journal of Cancer

Volumn 104, Issue 3, 2003, Pages 328-335

  Sasagawa, Toshiyuki ^a   Rose, Robert C ^b   Azar, Khadijeh K ^a   Sakai, Akemi ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Capsid; Cervical cancer; Mucosal antibody; Oncogenic

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY RESPONSE; ARTICLE; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUCOSAL IMMUNITY; MULTIVARIATE ANALYSIS; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CAPSID; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, NEOPLASM; ANTIBODIES, VIRAL; CAPSID; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX MUCUS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0037431426     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10939     Document Type: Article

References (23)

1. zur Hausen H. Papillomavirus in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res 1989;49:4677-81.
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
3. Matsukura T, Sugase M. Identification of genital human papilloma-viruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathological lesions. Int J Cancer 199;61:13-22.
4. Sasagawa T, Basha W, Yamazaki H, Inoue M. Oncogenic and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001;10:45-52.
5. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.J Natl Cancer Inst 2000;92:690-8.
6. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. Persistent type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
7. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papilloma-virus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
8. Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection Clin Diagn Lab Immunol 2001;8:209-20.
9. Kawano Y, Noma T, Yata J. Regulation of human IgG subclass production by cytokines. J. Immunol 1994;153:4948-58.
10. Snapper CM, Mond J. Towards a comprehensive view of Immun oglobulin class switching. Immunol Today 1993;14:15-7.
11. Kirunbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:474-5.
12. Giroglou T, Sapp M, Lane C, Fligge C, Christensen ND, Streeck RE, Rose RC. Immunological analyses of human papillomavirus capsids. Vaccine 2001;19:1783-93
13. Sasagawa T, Yamazaki H, Dong YZ, Satake S, Tateno M, Inoue M. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions. Int J Cancer 1998;75:529- 35.
14. Wang ZH, Kjellberg L, Abdalla H, Wiklund F, Eklund C, Knekt P, Lehtinen M, Kallings I, Lenner P, Hallmans G, Mahlck CG, Wadell G, et al. The type specific and significance of different isotypes of serum antibodies to human papillomavirus capsid. J I Infect Dis 2000;1181:456-62.
15. de Gruijl TD, Bontkes HJ, Walboomers JM, Schiller JT, Stukart MJ, Groot BS, Chabaud MM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:630-8.
16. Sasagawa T, Inoue M, Lehtinen M, Zhang W, Gschmeissner SE, Hajibagheri MA, Crawford L. Serological responses to human papil-lomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions. Clin Diagn Lab Immunol 1996;3:403-10.
17. Hagensee ME, Koutsky LA, Lee SK, Grubert T, Kuypers J, Kiviat NB, Galloway DA. Detection of cervical antibodies to human papil-lomavirus type 16 (HPV16) capsid antigen in relation to detection of HPV 16-DNA and cervical lesions. J Infect Dis 2000;181:1234-9.
18. Sasagawa T, Minemoto Y, Basha W, Yamazaki H, Nakamura M, Yoshimoto H, Sakaike J, Inoue M. A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res 2000;67:127-39.
19. Yamazaki H, Sasagawa T, Basha W, Segawa T, Inoue M. Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cyto-logic samples. Int J Cancer 2001;94:222-7
20. Rose RC, Bonnez W, Reichman RC, Garcea RL. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 1993;67:1936-44.
21. Rose RC, Bonnez W, Da Rin C., McCance DJ, Reichman RC. Serological differentiation of human papillomavirus types 11, 16, 18 using recombinant virus-like particles. J Gen Virol 1994;75:2445-9
22. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA. Comaparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911-19.
23. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases-United States. MMWR 1998;47:2-4.